BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Novartis AG (NVS) Sacks 18 for Fabricating Sales Data


6/12/2013 8:07:35 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Swiss drug maker Novartis AG’s Indian subsidiary has run into trouble with some executives allegedly found to be inflating and presenting fabricated sales data for industry-leading dipeptidyl peptidase-4 (DPP-4) inhibitor Galvus (vildagliptin). In swift retaliation, Novartis is believed to have issued marching orders to at least 18 executives and has launched a nationwide probe focused on remedial steps. According to information shared by well-placed industry sources, officials from mid-management ranks to sales representatives were allegedly involved in the unethical practices. Novartis uncovered the misconduct last month. Galvus franchise executives are now being investigated for allegedly padding invoices and then buying stocks of the diabetes drug from wholesalers with cash rewards that had been doled out as incentives, PharmAsia News has learned. The representatives registered false sales in an effort to match steep sales targets set for them, while in reality, no such heightened demand existed.

Help employers find you! Check out all the jobs and post your resume.


Read at Elsevier
Read at News Release
Read at News Release
Read at India Times

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES